Annual report pursuant to Section 13 and 15(d)

Acquisition (Narrative) (Details)

v3.7.0.1
Acquisition (Narrative) (Details) - USD ($)
1 Months Ended 4 Months Ended 12 Months Ended
Sep. 12, 2016
Nov. 30, 2016
Dec. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Business Acquisition [Line Items]          
Equity consideration issued for acquisition, number of shares       627,010  
Value of equity consideration issued for acquisition       $ 2,577,011  
Net loss       4,272,837 $ 8,757,565
BDI [Member]          
Business Acquisition [Line Items]          
Percentage of outstanding voting stock owned by parent 98.00%        
Common stock, par value   $ 0.001      
Aggregate cash consideration   $ 28,800      
Outstanding voting securities, percentage   1.10%      
Percentage of Venaxis common stock issued as equity consideration 14.00%        
Annual estimated future amortization for acquired finite-lived intangible assets     $ 492,000 492,000  
Revenue     9,000    
Net loss     967,000    
Amortization expense       148,000  
Advisory and legal fees related to the acquisition     130,000 130,000  
Inventories acquired     415,847 415,847  
Inventories raw materials acquired     187,921 187,921  
Inventories finished goods acquired     $ 227,926 $ 227,926  
BDI [Member] | Common Stock [Member]          
Business Acquisition [Line Items]          
Equity consideration issued for acquisition, number of shares 627,010        
Value of equity consideration issued for acquisition $ 2,577,000